US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels

 
• By Bridget Silverman

Another record-breaking year for novel approvals looks out of reach, but the six novel agents with November goal dates show the continued strength of rare disease drug development.

The FDA's November calendar includes user fee goal dates for six novel agents. (Shutterstock)

More from User Fee Goal Dates

More from United States